Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001649553-25-000191·BriaCell Therapeutics Corp.
Schedule 13G ownership disclosure
BRIACELL THERAPEUTICS CORP
Common Shares, no par value · CUSIP: 107930307
Event date: 2025-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- CVI Investments, Inc.
Shares: 98,944 · Class: 4.9%
- Heights Capital Management, Inc.
Shares: 98,944 · Class: 4.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001649553-25-000191
- Form type
- SCHEDULE 13G/A
- Filer
- BriaCell Therapeutics Corp.
- CIK
- CIK 1610820
- Filed
- Nov 07, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership